FDA Brief

Company record

AvKARE

0 FDA warning letters since 2023 and 3 recalls in the last 12 months.

Get an email the day FDA posts anything new about AvKARE.

Recalls

ReportedClassFirmProduct and reason
Nov 11 Class II AvKARE
Drug
Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15
Failed Impurities/Degradation Specifications
Mar 4 Class II AvKARE
Drug
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15.
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
Jan 14 Class II AvKARE
Drug
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
Out of specification for dissolution.